Physician profile
Han Jo Kim
NPI 1376710665
$3,919,794.02
in general payments reported to CMS, 2019-2025
27 companies · $1.1M in 2025
The $1.1M reported for 2025 was more than what 99% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $357K · 2020: $494K · 2021: $356K · 2022: $643K · 2023: $308K · 2024: $644K · 2025: $1.1M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.5M · Consulting Fee: $482K · Travel and Lodging: $48K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $33K · Food and Beverage: $18K · Gift: $548.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,489,090.63 |
| Consulting Fee | $482,119.01 |
| Travel and Lodging | $47,990.14 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $32,580.54 |
| Food and Beverage | $17,907.74 |
| Gift | $548.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,193,976.54 | 2019-2025 | Nile Alternative Fixation System, N/A |
| Highridge Medical LLC | $693,766.78 | 2024-2025 | Vital, Vitality, Vital Deformity, Degen, Hooks (S114) |
| Zimmer Biomet Holdings, INC. | $685,007.01 | 2019-2022 | |
| Zimvie INC. | $527,029.42 | 2022-2024 | |
| Alphatec Spine, INC | $222,982.13 | 2019-2025 | Other - Miscellaneous, Identiti, Arsenal Deformity |
| Vb Spine LLC | $196,933.66 | 2025 | Yukon Oct Spinal System |
| Orthofix Medical, INC. | $135,585.38 | 2020-2025 | Mariner Deformity, Mariner, 7d Surgical System |
| Acuity Surgical Devices, LLC | $99,994.58 | 2019-2025 | |
| Mirus, LLC | $46,693.41 | 2023-2024 | Europa Pedicle Screw System, Cygnus Anterior Cervical Plate, Io Expandable Lumbar Interbody |
| Medtronic, INC. | $36,381.86 | 2021-2025 | Unid_pass, Mazor X System |
| Si-Bone, INC. | $24,777.83 | 2020-2025 | |
| Theradaptive, INC. | $23,355.38 | 2025 | Osteoadapt |
| Nuvasive, INC. | $17,139.47 | 2019-2023 | Reline, Xlif, Tlif |
| Smaio Sa | $4,692.63 | 2023-2024 | |
| Globus Medical, INC. | $3,633.17 | 2024-2025 | External Fixation, Reline, Caliber |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smaio USA Corporation | $3,522.49 | 2024-2025 | |
| Osteocentric Technologies, INC. | $1,200.00 | 2024 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Smith+Nephew, INC. | $961.54 | 2021-2023 | |
| 4web, INC. | $493.32 | 2023-2024 | Spine Truss System |
| Ebi, LLC | $394.50 | 2025 | |
| Augmedics INC. | $278.98 | 2023 | Xvision |
| Medicrea USA, Corp. | $250.07 | 2019 | |
| Abyrx, INC | $217.64 | 2019 | |
| Axis Spine Technologies INC. | $191.86 | 2022 | |
| Depuy Synthes Sales INC. | $122.40 | 2019 | |
| Seaspine Orthopedics Corporation | $118.30 | 2021 | |
| Biedermann Motech, INC. | $93.67 | 2019-2023 | Moss Vrs Spinal System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,252,581.60 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Han Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.